{"title":"네이버 금융 ─ 뉴스 ─ 많이 본 뉴스","url":"https://finance.naver.com/news/news_list.naver?mode=RANK","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"[특징주] \"확진자 급증...재택치료 대폭 개선할 것\"...원격..","contents":"서울경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0003994420&office_id=011&mode=RANK&typ=0","retrieved":1638943701086},{"title":"[특징주] EDGC, 오미크론 PCR 검사 불가능 소식에…전장 ..","contents":"헤럴드경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0001922312&office_id=016&mode=RANK&typ=0","retrieved":1638943701073},{"title":"[특징주] 나노엔텍, ‘SK텔레콤 자회사’ 원격진료 수혜 부각↑","contents":"파이낸셜뉴스","link":"https://finance.naver.com/news/news_read.naver?article_id=0004752493&office_id=014&mode=RANK&typ=0","retrieved":1638947177673},{"title":"[특징주] 컴투스, 닥터나우와 원격의료 서비스 MOU 체결에 상..","contents":"아이뉴스24","link":"https://finance.naver.com/news/news_read.naver?article_id=0000641068&office_id=031&mode=RANK&typ=0","retrieved":1638958140000},{"title":"주가 100만원 갈까… 효성첨단소재, 올들어 380% '폭등'","contents":"머니S","link":"https://finance.naver.com/news/news_read.naver?article_id=0000762259&office_id=417&mode=RANK&typ=0","retrieved":1638940560000},{"title":"[특징주] 머큐리, 스마트그리드 사업 진출에 8%↑","contents":"머니S","link":"https://finance.naver.com/news/news_read.naver?article_id=0000762499&office_id=417&mode=RANK&typ=0","retrieved":1638943701084},{"title":"파우치 “오미크론 델타보다 확실히 덜 심각” 세계증시 일제 급등","contents":"뉴스1","link":"https://finance.naver.com/news/news_read.naver?article_id=0005770859&office_id=421&mode=RANK&typ=0","retrieved":1638946320000},{"title":"[특징주] 확진자수 7,000명 폭증세에 음압병실株 급등","contents":"서울경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0003994392&office_id=011&mode=RANK&typ=0","retrieved":1638943701088},{"title":"[특징주]컴투스, 원격의료 플랫폼 '닥터나우'와 업무협약 체결에..","contents":"파이낸셜뉴스","link":"https://finance.naver.com/news/news_read.naver?article_id=0004752378&office_id=014&mode=RANK&typ=0","retrieved":1638940012082},{"title":"5%룰 공시위반 제재 강화… 고객 예탁금 반환도 간소화","contents":"머니S","link":"https://finance.naver.com/news/news_read.naver?article_id=0000762278&office_id=417&mode=RANK&typ=0","retrieved":1638943680000},{"title":"[기업공시 12월 7일]현대중공업지주, 자회사 현대제뉴인 현대두..","contents":"서울경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0003994169&office_id=011&mode=RANK&typ=0","retrieved":1638946860000},{"title":"테슬라 4％ 이상 급등했는데 루시드는 2.18% 급락(종합)","contents":"뉴스1","link":"https://finance.naver.com/news/news_read.naver?article_id=0005770848&office_id=421&mode=RANK&typ=0","retrieved":1638944880000},{"title":"진격의 코스피 3000 돌파…16개월 만에 6거래일 연속 상승 ..","contents":"매일경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0004890559&office_id=009&mode=RANK&typ=0","retrieved":1638963660000},{"title":"[뉴욕증시]파우치 \"오미크론 덜 위협적\" 안심…나스닥 5% 급등","contents":"이데일리","link":"https://finance.naver.com/news/news_read.naver?article_id=0005102225&office_id=018&mode=RANK&typ=0","retrieved":1638947460000},{"title":"역대급 수주에도 맥 못추는 조선주···\"유가 살아나야 랠리 온다..","contents":"서울경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0003994161&office_id=011&mode=RANK&typ=0","retrieved":1638945060000},{"title":"[특징주] '메타버스 원격의료 추진' 컴투스 7.4% ↑","contents":"전자신문","link":"https://finance.naver.com/news/news_read.naver?article_id=0002986640&office_id=030&mode=RANK&typ=0","retrieved":1638943701109},{"title":"길어지는 박스피에… 증권가도 밸런스게임? \"현금\" VS \"경기민..","contents":"머니투데이","link":"https://finance.naver.com/news/news_read.naver?article_id=0004680479&office_id=008&mode=RANK&typ=0","retrieved":1638939060000},{"title":"금호에이치티, 두올물산 핵심 ‘오레고보맙’ 발표 “난소암 치료 ..","contents":"파이낸셜뉴스","link":"https://finance.naver.com/news/news_read.naver?article_id=0004752444&office_id=014&mode=RANK&typ=0","retrieved":1638943701112},{"title":"[뉴스새벽배송]오미크론 우려 완화에 상승랠리…나스닥, 3% ‘급..","contents":"이데일리","link":"https://finance.naver.com/news/news_read.naver?article_id=0005102264&office_id=018&mode=RANK&typ=0","retrieved":1638950820000},{"title":"한화·KTB·IBK투자, 신용등급 상향 업고 신사업 고삐","contents":"데일리안","link":"https://finance.naver.com/news/news_read.naver?article_id=0002555205&office_id=119&mode=RANK&typ=0","retrieved":1638939660000},{"title":"오미크론 우려 완화에 기술주 랠리...애플 3.5%↑ [출근전 ..","contents":"한국경제TV","link":"https://finance.naver.com/news/news_read.naver?article_id=0001002070&office_id=215&mode=RANK&typ=0","retrieved":1638946080000},{"title":"[뉴욕마감]나스닥 3%↑…오미크론 우려 완화에 안도랠리","contents":"뉴스1","link":"https://finance.naver.com/news/news_read.naver?article_id=0005770855&office_id=421&mode=RANK&typ=0","retrieved":1638945840000},{"title":"[특징주] 이오플로우, 450억원 규모 계약체결 소식에 강세","contents":"뉴스1","link":"https://finance.naver.com/news/news_read.naver?article_id=0005771259&office_id=421&mode=RANK&typ=0","retrieved":1638957840000},{"title":"오미크론 우려 지속 감소···나스닥 3.03%↑ [데일리 국제금..","contents":"서울경제","link":"https://finance.naver.com/news/news_read.naver?article_id=0003994157&office_id=011&mode=RANK&typ=0","retrieved":1638944280000},{"title":"코스피200 편입 종목 대차잔고 3배 급증…공매도 우려 확대","contents":"데일리안","link":"https://finance.naver.com/news/news_read.naver?article_id=0002555204&office_id=119&mode=RANK&typ=0","retrieved":1638939660000}]}